The personal investment firms of titans like Stanley Druckenmiller are backing innovations in gene editing, drug discovery and more. Investment firms of ultra-wealthy families are helping fuel the venture capital rebound in biotechnology.
Source: CNBC
Indexed: Fri, 04 Sep 2026 02:40:33 UTC
Not a government entity. Not a broker or agent. Public information index only. Verify independently.